Issues in the treatment of women with bipolar illness

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 15, 1997, Pages 5-11

  Leibenluft, Ellen ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b MSC 1390 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; CLOZAPINE; LEVOTHYROXINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HIGH RISK PATIENT; MANIC DEPRESSIVE PSYCHOSIS; MENSTRUAL CYCLE; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERAL PSYCHOSIS; REVIEW; SEX DIFFERENCE; TERATOGENESIS;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIPOLAR DISORDER; BUPROPION; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; MALE; MONOAMINE OXIDASE INHIBITORS; PREGNANCY; PREVALENCE; REPRODUCTION; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; VALPROIC ACID;

EID: 0031444181     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Robins L, Heizer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949-958
2. Kessler R, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19
3. Dunner D, Fieve R. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974;30:229-233
4. Dunner D, Patrick V, Fieve R. Rapid-cycling manic-depressive patients. Compr Psychiatry 1977;18:561-566
5. Cowdry R, Wehr T, Zis A, et al. Thyroid abnormalities associated with rapid-cycling bipolar illness. Arch Gen Psychiatry 1983;40:414-420
6. Bauer M, Whybrow P. Rapid cycling bipolar affective disorder, II: treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry 1990;47:435-440
7. Bauer MS, Calabrese J, Dunner DL, et al. Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 1994;151:506-515
8. Calabrese JR, Markovitz PJ, Kimmel SE, et al. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 1992; 12:53S-56S
9. Coryell W, Endicott J, Keller M. Rapid cycling affective disorder: demographics, diagnosis, family history, and course. Arch Gen Psychiatry 1992; 49:126-131
10. Kukopulos A, Reginaldi D, Laddomada G, et al. Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiat 1980; 13:156-157
11. Maj M, Magliano L, Pirozzi R, et al. Validity of rapid cycling as a course specifier for bipolar disorder. Am J Psychiatry 1994;151:1015-1019
12. Squillace K, Post RM, Savard R, et al. Life charting of the longitudinal course of recurrent affective illness. In: Post RM, Ballenger JC, eds. Neurobiology of Mood Disorders. Baltimore. Md: Williams & Wilkins; 1984: 38-59
13. Wehr T, Sack D, Rosenthal N, et al. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988;145:179-184
14. Bauer M, Whybrow P, Winokur A. Rapid cycling bipolar affective disorder, I: association with grade I hypothyroidism. Arch Gen Psychiatry 1990;47: 427-432
15. Leibenluft E. Women with bipolar illness: clinical and research issues. Am J Psychiatry 1996;153:163-173
16. Angst J. The course of affective disorders, II: typology of bipolar manic-depressive illness. Arch Psychiatr Nervenkr 1978;226:65-73
17. Roy-Byrne P, Post RM, Uhde TW, et al. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand 1985;71(317, suppl):5-32
18. Taschev T. The course and prognosis of depression on the basis of 652 patients deceased. In: Angst J, ed. Classification and Prediction of Outcome of Depression. Stuttgart: F.K. Schattauer Verlag; 1973:157-172
19. Winokur G, Coryell W, Akiskal HS, et al. Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. Acta Psychiatr Scand 1994;89:102-110
20. McElroy SL, Keck PE Jr, Pope HG Jr, et al. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992;149:1633-1644
21. McElroy S, Strakowski S, Keck PJ, et al. Differences and similarities in mixed and pure mania. Compr Psychiatry 1995;36:187-194
22. Bratfos O, Haug JO. Puerperal mental disorders in manic depressive females. Acta Psychiatr Scand 1966;42:285-294
23. Dean C, Williams RJ, Brockington IF. Is puerperal psychosis the same as bipolar manic-depressive disorder? a family study. Psychol Med 1989;19: 637-647
24. Kendell R, Chalmers J, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987;150:662-673
25. Reich T, Winokur G. Postpartum psychoses in patients with manic depressive disease. J Nerv Ment Dis 1970;151:60-68
26. Wehr T, Goodwin F. Biological rhythms in manic-depressive illness. In: Wehr T, Goodwin F, eds. Circadian Rhythms in Psychiatry. Pacific Grove, Calif: Boxwood Press; 1983:129-184
27. Roti E, Emerson CH. Postpartum thyroiditis. J Clin Endocrinol Metab 1992;74:3-5
28. O'Hara MW, Schlechte JA, Lewis DA, et al. Prospective study of postpartum blues. Arch Gen Psychiatry 1991;48:801-806
29. Ehlert U, Patalla U, Kirschbaum C, et al. Postpartum blues: salivary cortisol and psychological factors. J Psychosom Res 1990;34:319-325
30. Paykel ES, del Campo AM, White W, et al. Neuroendocrine challenge studies in puerperal psychoses: dexamethasone suppression and TRH stimulation. Br J Psychiatry 1991;159:262-266
31. Pop VJM, de Rooy HAM, Vader HL, et al. Postpartum thyroid dysfunction and depression in an unselected population. N Engl J Med 1991;324: 1815-1816
32. Pederson CA, Stern RA, Pate J, et al. Thyroid and adrenal measures during late pregnancy and the puerperium in women who have been major depressed or who become dysphoric postpartum. J Affect Disord 1993;29: 201-211
33. Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to lithium. JAMA 1994;271:146-150
34. Ang MS, Thorp JA, Parisi VM. Maternal lithium therapy and polyhydramnios. Obstet Gynecol 1990;76:517-518
35. Miller LJ. Psychiatric medication during pregnancy: understanding and minimizing risks. Psychiatr Ann 1994;24:69-75
36. Woody JN, London WL, Wilbanks GD. Lithium toxicity in a newborn. Pediatrics 1971;47:94-96
37. Troyer WA, Pereira GR, Lannon RA, et al. Association of maternal lithium exposure and premature delivery. J Perinatol 1993;13:123-127
38. Altshuler LL, Cohen L, Szuba MP, et al. Pharmacologic management of psychiatric illness in pregnancy: dilemmas and guidelines. Am J Psychiatry 1996;153:592-606
39. Dansky L, Rosenblatt D, Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992;42(5, suppl):32-42
40. Moslet U, Hansen ES. A review of vitamin K, epilepsy, and pregnancy. Acta Neurol Scand 1992;85:39-43
41. Gotlib I, Whiffen VE, Mount J, et al. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 1989;57:269-274
42. Frank E, Kupfer D, Jacob M, et al. Pregnancy-related affective episodes among women with recurrent depression. Am J Psychiatry 1987;144: 288-293
43. Lier L, Kastrup M, Rafealsen O. Psychiatric illness in relation to pregnancy and childbirth. II: diagnostic profiles, psychosocial and perinatal aspects. Nord PsykiatrTidsskr 1989;43:535-542
44. Diamond SB, Rubinstein AA, Dunner DL, et al. Menstrual problems in women with primary affective illness. Compr Psychiatry 1976;17:541-548
45. Price WA, DiMarzio L. Premenstrual tension syndrome in rapid-cycling bipolar affective disorder. J Clin Psychiatry 1986;47:415-417
46. Wehr T, Goodwin F. Tricyclics modulate frequency of manic-depressive cycles. Chronobiologia 1977;4:161
47. Wehr T, Goodwin F. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979;36:555-559
48. Hurowitz GI, Liebowitz MR. Antidepressant-induced rapid cycling: six case reports. J Clin Psychopharmacol 1993;13:52-56
49. Misra P, Burns B. Lithium "non-responders" in a lithium clinic. Acta Psychiatr Scand 1977;55:32-40
50. Calabrese JR, Woyshville MJ. A medication algorithm for treatment of bipolar rapid cycling? J Clin Psychiatry 1995;56(3, suppl):11-18
51. Okuma T. Effects of carbamazepine and lithium on affective disorder. Neuropsychobiology 1993;27:138-145
52. Calabrese JR, Woyshville MJ, Kimmel SE, et al. Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol 1993;13:280-283
53. Calabrese JR, Meltzer HY, Markovitz PJ. Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Psychopharmacol 1991;11:396-397
54. McElroy SL, Dessain EC, Pope HG Jr, et al. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-414
55. Suppes T, Phillips KA, Judd CR. Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiatry 1994; 36:338-340
56. Suppes T, Rush AJ, Webb A. Clozapine to treat severe and persistent bipolar disorder: preliminary results. Presented at the 34th annual meeting of the American College of Neuropsychopharmacology; Dec 11-15, 1995; San Juan, Puerto Rico; page 168
57. Pazzaglia PJ, Post RM, Ketter TA, et al. Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Res 1993;49:257-272
58. Wehr T, Goodwin F. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987;144:1403-1411
59. Quitkin F, Kane J, Rifkin A, et al. Prophylactic lithium carbonate with and without imipramine for bipolar I patients. Arch Gen Psychiatry 1981;38: 902-907
60. Lewis J, Winokur G. The induction of mania: a natural history study with controls. Arch Gen Psychiatry 1982;39:303-306
61. Haykal RF, Akiskal HS. Bupropion as a promising approach to rapid cycling bipolar II patients. J Clin Psychiatry 1990;51:450-455
62. Himmelhoch JM, Thase ME, Mallinger AG, et al. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991;148: 910-915
63. Montgomery SA. A review of the safety of paroxetine. Eur Psychiatry 1993;8(1, suppl):25-30
64. Simpson SG, DePaulo JR. Fluoxetine treatment of bipolar II depression. J Clin Psychopharmacol 1991;11:52-54
65. Wright G, Galloway L, Kim J, et al. Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects. J Clin Psychiatry 1985; 46:22-25
66. Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993;13:397-408
67. Christensen RC. Paroxetine-induced psychotic mania [letter]. Am J Psychiatry 1995;152:1399-1400
68. Fogelson DL, Bystritsky A, Pasnau R. Bupropion in the treatment of bipolar disorders: the same old story? J Clin Psychiatry 1992;53:443-446
69. Turner SM, Jacob RG, Beidel DC, et al. A second case of mania associated with fluoxetine [letter]. Am J Psychiatry 1985;142:274-275
70. Venkataraman S, Naylor MW, King CA. Mania associated with fluoxetine treatment in adolescents. J Am Acad Child Adolesc Psychiatry 1992;31: 276-281
71. Zubieta JK, Demitrack MA. Possible bupropion precipitation of mania and a mixed affective state. J Clin Psychopharmacol 1991;11:327-328
72. Stoll AL, Mayer PV, Kolbrener M, et al. Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry 1994; 151:1642-1645
73. Goodwin F, Jamison K. Manic-Depressive Illness. New York. NY: Oxford University Press; 1990:639-640
74. Watanabe S, Ishino H, Otsuki S. Double-blind comparison of lithium and imipramine in treatment of depression. Arch Gen Psychiatry 1975;32: 659-668
75. Fieve RR, Platman SR, Plutchik RR. The use of lithium in affective disorders, I: acute endogenous depression. Am J Psychiatry 1968;125:79-83
76. Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980;7:782-790
77. Post RM, Uhde TW, Ballenger JC, et al. Carbamazepine and its -10.11-epoxide metabolite in plasma and CSF: relationship to antidepressant response. Arch Gen Psychiatry 1983;40:673-676
78. Kramlinger KG, Post RM. The addition of lithium to carbamazepine. Arch Gen Psychiatry 1989;46:794-800
79. McElroy SL, Keck PE Jr, Pope HG Jr, et al. Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. J Clin Psychopharmacol 1992;12:42S-52S
80. Calabrese J, Markovitz P, Wagner S. Predictors of valproate response in rapid-cycling bipolar disorder. Biol Psychiatry 1991;29:166A-167A
81. Thase ME, Mallinger AG, McKnight D, et al. Treatment of imipramine-resistant recurrent depression, IV: a double-blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry 1992;149: 195-198
82. Ketter TA, Post RM, Parekh PI, et al. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. J Clin Psychiatry 1995;56: 471-475
83. Cohn JB, Collins G, Ashbrook E, et al. A comparison of fluoxetine, imipramine, and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989;4:313-322
84. Sachs GS, Lafer B, Stoll AL, et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994;55:391-393
85. Bratfos O, Haug JO. Electroconvulsive therapy and antidepressant drugs in manic-depressive disease. Acta Psychiatr Scand 1965;41:588-596
86. Devanand DP, Sackheim HA, Decina P, et al. The development of mania and organic euphoria during ECT. J Clin Psychiatry 1988;49:69-71
87. Endo M, Daiguji M, Asano Y, et al. Periodic psychosis recurring in association with menstrual cycle. J Clin Psychiatry 1978;39:456-461,465-466
88. Brockington IF, Kelly A, Hall P, et al. Premenstrual relapse of puerperal psychosis. J Affect Disord 1988;14:287-292
89. Klompenhouwer JL, van Hulst AM. Classification of postpartum psychosis: a study of 250 mother and baby admissions in the Netherlands. Acta Psychiatr Scand 1991;84:255-261